Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A

Por Garg, A D, Dudek, A M, Agostinis, P
Publicado em 2013

Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity

Por Stish, B J, Oh, S, Chen, H, Dudek, A Z, Kratzke, R A, Vallera, D A
Publicado em 2009

Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy

Por Dudek, A Z, Bodempudi, V, Welsh, B W, Jasinski, P, Griffin, R J, Milbauer, L, Hebbel, R P
Publicado em 2007

Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor

Por Dudek, A Z, Lesniewski-Kmak, K, Shehadeh, N J, Pandey, O N, Franklin, M, Kratzke, R A, Greeno, E W, Kumar, P
Publicado em 2009

MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8...

Por Østergaard, M, Jacobsson, L T H, Schaufelberger, C, Hansen, M Sejer, Bijlsma, J W J, Dudek, A, Rell-Bakalarska, M, Staelens, F, Haake, R, Sundman-Engberg, B, Bliddal, H
Publicado no Ann Rheum Dis (2015)

Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency

Por Elgizouli, M., Lowe, D. M., Speckmann, C., Schubert, D., Hülsdünker, J., Eskandarian, Z., Dudek, A., Schmitt‐Graeff, A., Wanders, J., Jørgensen, S. F., Fevang, B., Salzer, U., Nieters, A., Burns, S., Grimbacher, B.
Publicado no Clin Exp Immunol (2015)

SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours

Por Khatri, A, Williams, B W, Fisher, J, Brundage, R C, Gurvich, V J, Lis, L G, Skubitz, K M, Dudek, A Z, Greeno, E W, Kratzke, R A, Lamba, J K, Kirstein, M N
Publicado em 2014